| 1 |
34205047 | Novel Pharmaceutical Strategy for Selective Abrogation of TSP1-Induced Vascular Dysfunction by Decoy Recombinant CD47 Soluble Receptor in Prophylaxis and Treatment Models. | 2021 Jun 3 |
1 |
| 2 |
29788500 | Microvascular Dysfunction Following Multiwalled Carbon Nanotube Exposure Is Mediated by Thrombospondin-1 Receptor CD47. | 2018 Sep 1 |
1 |
| 3 |
29979224 | MicroRNA-155 Amplifies Nitric Oxide/cGMP Signaling and Impairs Vascular Angiotensin II Reactivity in Septic Shock. | 2018 Sep |
2 |
| 4 |
27331362 | Attenuation of Ischemia-Reperfusion Injury and Improvement of Survival in Recipients of Steatotic Rat Livers Using CD47 Monoclonal Antibody. | 2016 Jul |
1 |
| 5 |
25482981 | CD47 blockade reduces ischemia/reperfusion injury and improves survival in a rat liver transplantation model. | 2015 Apr |
3 |
| 6 |
20923780 | Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. | 2010 Dec 10 |
1 |
| 7 |
18187671 | CD47: a new target in cardiovascular therapy. | 2008 Apr |
1 |